Upsher-Smith Laboratories Announces Expansion of Voluntary Nationwide Recall. Affected Products Include Amantadine, Amlodipine, Androxy, Baclofen, Bethanechol, Jantoven® and Oxybutynin
Links shared publicly online about this topic.
- 495total visits
Upsher-Smith Laboratories Announces Expansion of Voluntary Nationwide Recall. Affected Products Include Amantadine, Amlodipine, Androxy, Baclofen, Bethanechol, Jantoven® and Oxybutynin
fda.gov —
Upsher-Smith Laboratories, Inc., of Maple Grove, Minnesota is voluntarily expanding its previously announced recall of Jantoven® Warfarin Sodium, USP, 3 mg Tablets to include additional products that were packaged on the same packaging line between May 17, 2010 and November 17, 2010. The company is initiating the recall as a precautionary measure after a bottle labeled as Jantoven® Warfarin Sodium, USP, 3 mg Tablets was found by a retail pharmacy to contain tablets at a higher, 10 mg str
View full resource at fda.gov
Tags: Angina Medication, High Blood Pressure Medication, Parkinson's Disease Medication, Drug, Calcium Channel Blocker, Norvasc, Symmetrel
Most Recently Shared on February 24, 2011 at 2:07 pm By:
Expansion of Nationwide Recall: Amantadine, Amlodipine, Androxy, Baclofen, Bethanechol, Jantoven, Oxybutynin: http://bit.ly/eTEeN3
Also Shared By:
Advertisement
Ohio Family Practice
@OFPC
Drug recall expanded to include: Amantadine, Amlodipine, Baclofen, Bethanechol, Jantoven® and Oxybutynin http://goo.gl/5hQnK
1 year ago...